Molecular imaging in neuroscience research with small-animal PET in rodents

Neuroscience Research

Volumn 70, Issue 2, 2011, Pages 133-143

  Xi, Wang ^a,b,c   Tian, Mei ^d   Zhang, Hong ^a,b,c  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c Key Laboratory of Medical Molecular Imaging of Zhejiang Province   (China)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cognition; Dopamine; FDG; Rodents; Small animal PET

Indexed keywords

BRAIN RECEPTOR; TRACER;

BRAIN FUNCTION; CHOLINERGIC SYSTEM; DOPAMINERGIC SYSTEM; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GABAERGIC SYSTEM; GLUCOSE METABOLISM; HUMAN; MOLECULAR IMAGING; NEUROIMAGING; NEUROSCIENCE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SEROTONINERGIC SYSTEM;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MAGNETIC RESONANCE IMAGING; MICE; NEUROSCIENCES; NEUROTRANSMITTER AGENTS; POSITRON-EMISSION TOMOGRAPHY; RATS; RODENTIA;

EID: 79955643487     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2010.12.017     Document Type: Review

References (113)

1. Ametamey S.M., Kessler L.J., Honer M., Wyss M.T., Buck A., Hintermann S., Auberson Y.P., Gasparini F., Schubiger P.A. Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5. J. Nucl. Med. 2006, 47:698-705.
2. Asselin M.C., Montgomery A.J., Grasby P.M., Hume S.P. Quantification of PET studies with the very high-affinity dopamine D2/D3 receptor ligand [11C]FLB 457: re-evaluation of the validity of using a cerebellar reference region. J. Cereb. Blood Flow Metab. 2007, 27:378-392.
3. Aznavour N., Benkelfat C., Gravel P., Aliaga A., Rosa-Neto P., Bedell B., Zimmer L., Descarries L. MicroPET imaging of 5-HT 1A receptors in rat brain: a test-retest [18F]MPPF study. Eur. J. Nucl. Med. Mol. Imaging 2009, 36:53-62.
4. Backman L., Ginovart N., Dixon R.A., Wahlin T.B., Wahlin A., Halldin C., Farde L. Age-related cognitive deficits mediated by changes in the striatal dopamine system. Am. J. Psychiatry 2000, 157:635-637.
5. Backman L., Nyberg L., Lindenberger U., Li S.C., Farde L. The correlative triad among aging, dopamine, and cognition: current status and future prospects. Neurosci. Biobehav. Rev. 2006, 30:791-807.
6. Badgaiyan R.D., Fischman A.J., Alpert N.M. Striatal dopamine release in sequential learning. Neuroimage 2007, 38:549-556.
7. Baete K., Nuyts J., Van Laere K., Van Paesschen W., Ceyssens S., De Ceuninck L., Gheysens O., Kelles A., Van den Eynden J., Suetens P., Dupont P. Evaluation of anatomy based reconstruction for partial volume correction in brain FDG-PET. Neuroimage 2004, 23:305-317.
8. Barker A.T., Jalinous R., Freeston I.L. Non-invasive magnetic stimulation of human motor cortex. Lancet 1985, 1:1106-1107.
9. Bergsneider M., Hovda D.A., Shalmon E., Kelly D.F., Vespa P.M., Martin N.A., Phelps M.E., McArthur D.L., Caron M.J., Kraus J.F., Becker D.P. Cerebral hyperglycolysis following severe traumatic brain injury in humans: a positron emission tomography study. J. Neurosurg. 1997, 86:241-251.
10. Bhave G., Nadin B.M., Brasier D.J., Glauner K.S., Shah R.D., Heinemann S.F., Karim F., Gereau R.W. Membrane topology of a metabotropic glutamate receptor. J. Biol. Chem. 2003, 278:30294-30301.
11. Brooks D.J., Piccini P. Imaging in Parkinson's disease: the role of monoamines in behavior. Biol. Psychiatry 2006, 59:908-918.
12. Bruno V., Battaglia G., Copani A., D'Onofrio M., Di Iorio P., De Blasi A., Melchiorri D., Flor P.J., Nicoletti F. Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs. J. Cereb. Blood Flow Metab. 2001, 21:1013-1033.
13. Carlsson A., Lindqvist M., Magnusson T., Waldeck B. On the presence of 3-hydroxytyramine in brain. Science 1958, 127:471.
14. Casteels C., Lauwers E., Bormans G., Baekelandt V., Van Laere K. Metabolic-dopaminergic mapping of the 6-hydroxydopamine rat model for Parkinson's disease. Eur. J. Nucl. Med. Mol. Imaging 2008, 35:124-134.
15. Casteels C., Vermaelen P., Nuyts J., Van Der Linden A., Baekelandt V., Mortelmans L., Bormans G., Van Laere K. Construction and evaluation of multitracer small-animal PET probabilistic atlases for voxel-based functional mapping of he rat brain. J. Nucl. Med. 2006, 47:1858-1866.
16. 18)F]MK-9470 binding to the type 1 cannabinoid receptor in the rat brain. Eur. J. Nucl. Med. Mol. Imaging 2010, 37:1164-1173.
17. Casteels C., Lauwers E., Baitar A., Bormans G., Baekelandt V., Van Laere K. In vivo type 1 cannabinoid receptor mapping in the 6-hydroxydopamine lesion rat model of Parkinson's disease. Brain Res. 2010, 1316:153-162.
18. Casteels C., Vanbilloen B., Vercammen D., Bosier B., Lambert D.M., Bormans G., Van Laere K. Influence of chronic bromocriptine and levodopa administration on cerebral type 1 cannabinoid receptor binding. Synapse 2010, 64:617-623.
19. Chugani H.T., Jacobs B. Metabolic recovery in caudate nucleus of children following cerebral hemispherectomy. Ann. Neurol. 1994, 36:794-797.
20. Conn P.J., Pin J.P. Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol. 1997, 37:205-237.
21. Dedeurwaerdere S., Gregoire M.C., Vivash L., Roselt P., Binns D., Fookes C., Greguric I., Pham T., Loc'h C., Katsifis A., Hicks R.J., O'Brien T.J., Myers D.E. In-vivo imaging characteristics of two fluorinated flumazenil radiotracers in the rat. Eur. J. Nucl. Med. Mol. Imaging 2009, 36:958-965.
22. Dolan R.J. Neuroimaging of cognition: past, present, and future. Neuron 2008, 60:496-502.
23. Easwaramoorthy B., Pichika R., Collins D., Potkin S.G., Leslie F.M., Mukherjee J. Effect of acetylcholinesterase inhibitors on the binding of nicotinic alpha4beta2 receptor PET radiotracer, (18)F-nifene: a measure of acetylcholine competition. Synapse 2007, 61:29-36.
24. 11C]raclopride PET studies in the rat. Psychopharmacology (Berl) 2008, 200:487-496.
25. Erixon-Lindroth N., Farde L., Wahlin T.B., Sovago J., Halldin C., Backman L. The role of the striatal dopamine transporter in cognitive aging. Psychiatry Res. 2005, 138:1-12.
26. Farde L., Gustavsson J.P., Jonsson E. D2 dopamine receptors and personality traits. Nature 1997, 385:590.
27. Fletcher A., Cliffe I.A., Dourish C.T. Silent 5-HT1A receptor antagonists: utility as research tools and therapeutic agents. Trends Pharmacol. Sci. 1993, 14:41-48.
28. Fox P.T., Mintun M.A., Reiman E.M., Raichle M.E. Enhanced detection of focal brain responses using intersubject averaging and change-distribution analysis of subtracted PET images. J. Cereb. Blood Flow Metab. 1988, 8:642-653.
29. Friston K.J., Frith C.D., Liddle P.F., Frackowiak R.S. Comparing functional (PET) images: the assessment of significant change. J. Cereb. Blood Flow Metab. 1991, 11:690-699.
30. Statistical Parametric Mapping: The Analysis of Functional Brain Images 2007, Elsevier, Oxford, United Kingdom. K.J. Friston, J.T. Ashburner, S.J. Kiebel, T.E. Nichols, W.D. Penny (Eds.).
31. Heiss W.D., Herholz K. Brain receptor imaging. J. Nucl. Med. 2006, 47:302-312.
32. Hjornevik T., Leergaard T.B., Darine D., Moldestad O., Dale A.M., Willoch F., Bjaalie J.G. Three-dimensional atlas system for mouse and rat brain imaging data. Front. Neuroinformatics 2007, 1:4.
33. Hoffman E.J., Huang S.C., Phelps M.E. Quantitation in positron emission computed tomography: 1. Effect of object size. J. Comput. Assist. Tomogr. 1979, 3:299-308.
34. Hosoi R., Matsumura A., Mizokawa S., Tanaka M., Nakamura F., Kobayashi K., Watanabe Y., Inoue O. MicroPET detection of enhanced 18F-FDG utilization by PKA inhibitor in awake rat brain. Brain Res. 2005, 1039:199-202.
35. Huang S.C., Wu H.M., Shoghi-Jadid K., Stout D.B., Chatziioannou A., Schelbert H.R., Barrio J.R. Investigation of a new input function validation approach for dynamic mouse microPET studies. Mol. Imaging Biol. 2004, 6:34-46.
36. Hume S.P., Gunn R.N., Jones T. Pharmacological constraints associated with positron emission tomographic scanning of small laboratory animals. Eur. J. Nucl. Med. 1998, 25:173-176.
37. Iglesias S., Marchal G., Rioux P., Beaudouin V., Hauttement A.J., de la Sayette V., Le Doze F., Derlon J.M., Viader F., Baron J.C. Do changes in oxygen metabolism in the unaffected cerebral hemisphere underlie early neurological recovery after stroke? A positron emission tomography study. Stroke 1996, 27:1192-1199.
38. 11C]N-methylspiperone. Nucl. Med. Biol. 2002, 29:307-316.
39. 11C-(R)-rolipram and the density of its target, phosphodiesterase-4, in the brains of conscious and anesthetized rats. J. Nucl. Med. 2009, 50:749-756.
40. Jagoda E.M., Lang L., Tokugawa J., Simmons A., Ma Y., Contoreggi C., Kiesewetter D., Eckelman W.C. Development of 5-HT1A receptor radioligands to determine receptor density and changes in endogenous 5-HT. Synapse 2006, 59:330-341.
41. Jang D.P., Lee S.H., Lee S.Y., Park C.W., Cho Z.H., Kim Y.B. Neural responses of rats in the forced swimming test: [F-18]FDG micro PET study. Behav. Brain Res. 2009, 203:43-47.
42. Jones T. The role of positron emission tomography within the spectrum of medical imaging. Eur. J. Nucl. Med. 1996, 23:207-211.
43. Kaasinen V., Nurmi E., Bruck A., Eskola O., Bergman J., Solin O., Rinne J.O. Increased frontal [(18)F]fluorodopa uptake in early Parkinson's disease: sex differences in the prefrontal cortex. Brain 2001, 124:1125-1130.
44. Kim J., Herrero P., Sharp T., Laforest R., Rowland D.J., Tai Y.C., Lewis J.S., Welch M.J. Minimally invasive method of determining blood input function from PET images in rodents. J. Nucl. Med. 2006, 47:330-336.
45. Koepp M.J., Gunn R.N., Lawrence A.D., Cunningham V.J., Dagher A., Jones T., Brooks D.J., Bench C.J., Grasby P.M. Evidence for striatal dopamine release during a video game. Nature 1998, 393:266-268.
46. Kornblum H.I., Araujo D.M., Annala A.J., Tatsukawa K.J., Phelps M.E., Cherry S.R. In vivo imaging of neuronal activation and plasticity in the rat brain by high resolution positron emission tomography (microPET). Nat. Biotechnol. 2000, 18:655-660.
47. Krieger P., Hellgren-Kotaleski J., Kettunen P., El Manira A.J. Interaction between metabotropic and ionotropic glutamate receptors regulates neuronal network activity. J. Neurosci. 2000, 20:5382-5391.
48. Kung M.P., Kung H.F. Mass effect of injected dose in small rodent imaging by SPECT and PET. Nucl. Med. Biol. 2005, 32:673-678.
49. Laforest R., Sharp T.L., Engelbach J.A., Fettig N.M., Herrero P., Kim J., Lewis J.S., Rowland D.J., Tai Y.C., Welch M.J. Measurement of input functions in rodents: challenges and solutions. Nucl. Med. Biol. 2005, 32:679-685.
50. Lammertsma A.A. Role of human and animal PET studies in drug development. Int. Congr. Ser. 2004, 1265:3-11.
51. Lancelot S., Zimmer L. Small-animal positron emission tomography as a tool for neuropharmacology. Trends Pharmacol. Sci. 2010, 31:411-417.
52. Lawrence A.D., Weeks R.A., Brooks D.J., Andrews T.C., Watkins L.H., Harding A.E., Robbins T.W., Sahakian B.J. The relationship between striatal dopamine receptor binding and cognitive performance in Huntington's disease. Brain 1998, 121(Pt 7):1343-1355.
53. Lemoine L., Verdurand M., Vacher B., Blanc E., Le Bars D., Newman-Tancredi A., Zimmer L. [18F]F15599, a novel 5-HT1A receptor agonist, as a radioligand for PET neuroimaging. Eur. J. Nucl. Med. Mol. Imaging 2010, 37:594-605.
54. Liefaard L.C., Ploeger B.A., Molthoff C.F., de Jong H.W., Dijkstra J., van der Weerd L., Lammertsma A.A., Danhof M., Voskuyl R.A. Changes in GABAA receptor properties in amygdala kindled animals: in vivo studies using [11C]flumazenil and positron emission tomography. Epilepsia 2009, 50:88-98.
55. Liu L., Wang Y., Li B., Jia J., Sun Z., Zhang J., Tian J., Wang X. Evaluation of nigrostriatal damage and its change over weeks in a rat model of Parkinson's disease: small animal positron emission tomography studies with [(11)C]beta-CFT. Nucl. Med. Biol. 2009, 36:941-947.
56. Lundquist P., Roman M., Syvanen S., Hartvig P., Blomquist G., Hammarlund-Udenaes M., Langstrom B. Effect on [11C]DASB binding after tranylcypromine-induced increase in serotonin concentration: positron emission tomography studies in monkeys and rats. Synapse 2007, 61:440-449.
57. Matsumura A., Mizokawa S., Tanaka M., Wada Y., Nozaki S., Nakamura F., Shiomi S., Ochi H., Watanabe Y. Assessment of microPET performance in analyzing the rat brain under different types of anesthesia: comparison between quantitative data obtained with microPET and ex vivo autoradiography. Neuroimage 2003, 20:2040-2050.
58. McGowan S., Lawrence A.D., Sales T., Quested D., Grasby P. Presynaptic dopaminergic dysfunction in schizophrenia: a positron emission tomographic [18F]fluorodopa study. Arch. Gen. Psychiatry 2004, 61:134-142.
59. Meldrum B.S. Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J. Nutr. 2000, 130:1007S-1015S.
60. Mirrione M.M., Schiffer W.K., Fowler J.S., Alexoff D.L., Dewey S.L., Tsirka S.E. A novel approach for imaging brain-behavior relationships in mice reveals unexpected metabolic patterns during seizures in the absence of tissue plasminogen activator. Neuroimage 2007, 38:34-42.
61. Mirrione M.M., Schiffer W.K., Siddiq M., Dewey S.L., Tsirka S.E. PET imaging of glucose metabolism in a mouse model of temporal lobe epilepsy. Synapse 2006, 59:119-121.
62. Mizuma H., Shukuri M., Hayashi T., Watanabe Y., Onoe H. Establishment of in vivo brain imaging method in conscious mice. J. Nucl. Med. 2010, 51:1068-1075.
63. Momosaki S., Hatano K., Kawasumi Y., Kato T., Hosoi R., Kobayashi K., Inoue O., Ito K. Rat-PET study without anesthesia: anesthetics modify the dopamine D1 receptor binding in rat brain. Synapse 2004, 54:207-213.
64. Mozley L.H., Gur R.C., Mozley P.D., Gur R.E. Striatal dopamine transporters and cognitive functioning in healthy men and women. Am. J. Psychiatry 2001, 158:1492-1499.
65. Muller R.A., Chugani H.T., Muzik O., Mangner T.J. Brain organization of motor and language functions following hemispherectomy: a [(15)O]-water positron emission tomography study. J. Child Neurol. 1998, 13:16-22.
66. Nikolaus S., Larisch R., Beu M., Hamacher K., Forutan F., Vosberg H., Muller H.W. In vivo measurement of D2 receptor density and affinity for 18F-(3-N-methyl)benperidol in the rat striatum with a PET system for small laboratory animals. J. Nucl. Med. 2003, 44:618-624.
67. Ogawa S., Lee T.M., Kay A.R., Tank D.W. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc. Natl. Acad. Sci. USA 1990, 87:9868-9872.
68. Ogawa S., Lee T.M., Nayak A.S., Glynn P. Oxygenation-sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields. Magn. Reson. Med. 1990, 14:68-78.
69. Ohashi K., Ichikawa K., Chen L., Callahan M., Zasadny K., Kurebayashi Y. MicroPET detection of regional brain activation induced by colonic distention in a rat model of visceral hypersensitivity. J. Vet. Med. Sci. 2008, 70:43-49.
70. Patel V.D., Lee D.E., Alexoff D.L., Dewey S.L., Schiffer W.K. Imaging dopamine release with Positron Emission Tomography (PET) and (11)C-raclopride in freely moving animals. Neuroimage 2008, 41:1051-1066.
71. Paul A.K., Lobarinas E., Simmons R., Wack D., Luisi J.C., Spernyak J., Mazurchuk R., Abdel-Nabi H., Salvi R. Metabolic imaging of rat brain during pharmacologically-induced tinnitus. Neuroimage 2009, 44:312-318.
72. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 2005, Elsevier, Oxford, United Kingdom.
73. Pedersen K., Simonsen M., Ostergaard S.D., Munk O.L., Rosa-Neto P., Olsen A.K., Jensen S.B., Moller A., Cumming P. Mapping the amphetamine-evoked changes in [11C]raclopride binding in living rat using small animal PET: modulation by MAO-inhibition. Neuroimage 2007, 35:38-46.
74. Petersen S.E., Fox P.T., Posner M.I., Mintun M., Raichle M.E. Positron emission tomographic studies of the cortical anatomy of single-word processing. Nature 1988, 331:585-589.
75. Plenevaux A., Weissmann D., Aerts J., Lemaire C., Brihaye C., Degueldre C., Le Bars D., Comar D., Pujol J., Luxen A. Tissue distribution, autoradiography, and metabolism of 4-(2'-methoxyphenyl)-1-[2' -[N-2″-pyridinyl)-p-[(18)F]fluorobenzamido]ethyl]piperazine (p-[(18)F]MPPF), a new serotonin 5-HT(1A) antagonist for positron emission tomography: an in vivo study in rats. J. Neurochem. 2000, 75:803-811.
76. Posner M.I., Petersen S.E., Fox P.T., Raichle M.E. Localization of cognitive operations in the human brain. Science 1988, 240:1627-1631.
77. Reeves S.J., Grasby P.M., Howard R.J., Bantick R.A., Asselin M.C., Mehta M.A. A positron emission tomography (PET) investigation of the role of striatal dopamine (D2) receptor availability in spatial cognition. Neuroimage 2005, 28:216-226.
78. Rinne J.O., Portin R., Ruottinen H., Nurmi E., Bergman J., Haaparanta M., Solin O. Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study. Arch. Neurol. 2000, 57:470-475.
79. Rubins D.J., Melega W.P., Lacan G., Way B., Plenevaux A., Luxen A., Cherry S.R. Development and evaluation of an automated atlas-based image analysis method for microPET studies of the rat brain. Neuroimage 2003, 20:2100-2118.
80. Saigal N., Pichika R., Easwaramoorthy B., Collins D., Christian B.T., Shi B., Narayanan T.K., Potkin S.G., Mukherjee J. Synthesis and biologic evaluation of a novel serotonin 5-HT1A receptor radioligand, 18F-labeled mefway, in rodents and imaging by PET in a nonhuman primate. J. Nucl. Med. 2006, 47:1697-1706.
81. Saijo T., Maeda J., Okauchi T., Morio Y., Kuwahara Y., Suzuki M., Goto N., Suzuki K., Higuchi M., Suhara T. Utility of small-animal positron emission tomographic imaging of rats for preclinical development of drugs acting on the serotonin transporter. Int. J. Neuropsychopharmacol. 2009, 12:1021-1032.
82. Schaffhauser H., Rowe B.A., Morales S., Chavez-Noriega L.E., Yin R., Jachec C., Rao S.P., Bain G., Pinkerton A.B., Vernier J.M., Bristow L.J., Varney M.A., Daggett L.P. Pharmacological characterization and identification of amino acids involved in the positive modulation of metabotropic glutamate receptor subtype 2. Mol. Pharmacol. 2003, 64:798-810.
83. Schiffer W.K., Liebling C.N., Reiszel C., Hooker J.M., Brodie J.D., Dewey S.L. Cue-induced dopamine release predicts cocaine preference: positron emission tomography studies in freely moving rodents. J. Neurosci. 2009, 29:6176-6185.
84. Schiffer W.K., Mirrione M.M., Dewey S.L. Optimizing experimental protocols for quantitative behavioral imaging with 18F-FDG in rodents. J. Nucl. Med. 2007, 48:277-287.
85. Schultz W., Dayan P., Montague P.R. A neural substrate of prediction and reward. Science 1997, 275:1593-1599.
86. Schweinhardt P., Fransson P., Olson L., Spenger C., Andersson J.L. A template for spatial normalisation of MR images of the rat brain. J. Neurosci. Methods 2003, 129:105-113.
87. Seneca N., Zoghbi S.S., Skinbjerg M., Liow J.S., Hong J., Sibley D.R., Pike V.W., Halldin C., Innis R.B. Occupancy of dopamine D2/3 receptors in rat brain by endogenous dopamine measured with the agonist positron emission tomography radioligand [11C]MNPA. Synapse 2008, 62:756-763.
88. Shetty H.U., Zoghbi S.S., Liow J.S., Ichise M., Hong J., Musachio J.L., Halldin C., Seidel J., Innis R.B., Pike V.W. Identification and regional distribution in rat brain of radiometabolites of the dopamine transporter PET radioligand [11C]PE2I. Eur. J. Nucl. Med. Mol. Imaging 2007, 34:667-678.
89. Shimoji K., Ravasi L., Schmidt K., Soto-Montenegro M.L., Esaki T., Seidel J., Jagoda E., Sokoloff L., Green M.V., Eckelman W.C. Measurement of cerebral glucose metabolic rates in the anesthetized rat by dynamic scanning with 18F-FDG, the ATLAS small animal PET scanner, and arterial blood sampling. J. Nucl. Med. 2004, 45:665-672.
90. Sossi V., Holden J.E., Topping G.J., Camborde M.L., Kornelsen R.A., McCormick S.E., Greene J., Studenov A.R., Ruth T.J., Doudet D.J. In vivo measurement of density and affinity of the monoamine vesicular transporter in a unilateral 6-hydroxydopamine rat model of PD. J. Cereb. Blood Flow Metab. 2007, 27:1407-1415.
91. Sossi V., Dinelle K., Topping G.J., Holden J.E., Doudet D., Schulzer M., Ruth T.J., Stoessl A.J., de la Fuente-Fernandez R. Dopamine transporter relation to levodopa-derived synaptic dopamine in a rat model of Parkinson's: an in vivo imaging study. J. Neurochem. 2009, 109:85-92.
92. Spooren W.P., Gasparini F., Salt T.E., Kuhn R. Novel allosteric antagonists shed light on mglu(5) receptors and CNS disorders. Trends Pharmacol. Sci. 2001, 22:331-337.
93. Schwartz R.A., Greenwald E.R., Fletcher P.J., Houle S., DaSilva J.N. Up-regulated dopamine D1 receptor binding can be detected in vivo following repeated SCH 23390, but not SKF 81297 or 6-hydroxydopamine, treatments. Eur. J. Pharmacol. 2003, 459:195-201.
94. Sung K.K., Jang D.P., Lee S., Kim M., Lee S.Y., Kim Y.B., Park C.W., Cho Z.H. Neural responses in rat brain during acute immobilization stress: a [F-18]FDG micro PET imaging study. Neuroimage 2009, 44:1074-1080.
95. Tatarczynska E., Klodzinska A., Chojnacka-Wojcik E., Palucha A., Gasparini F., Kuhn R., Pilc A. Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist. Br. J. Pharmacol. 2001, 132:1423-1430.
96. Tipre D.N., Zoghbi S.S., Liow J.S., Green M.V., Seidel J., Ichise M., Innis R.B., Pike V.W. PET imaging of brain 5-HT1A receptors in rat in vivo with 18F-FCWAY and improvement by successful inhibition of radioligand defluorination with miconazole. J. Nucl. Med. 2006, 47:345-353.
97. Tokugawa J., Ravasi L., Nakayama T., Lang L., Schmidt K.C., Seidel J., Green M.V., Sokoloff L., Eckelman W.C. Distribution of the 5-HT(1A) receptor antagonist [(18)F]FPWAY in blood and brain of the rat with and without isoflurane anesthesia. Eur. J. Nucl. Med. Mol. Imaging 2007, 34:259-266.
98. Tokunaga M., Seneca N., Shin R.M., Maeda J., Obayashi S., Okauchi T., Nagai Y., Zhang M.R., Nakao R., Ito H., Innis R.B., Halldin C., Suzuki K., Higuchi M., Suhara T. Neuroimaging and physiological evidence for involvement of glutamatergic transmission in regulation of the striatal dopaminergic system. J. Neurosci. 2009, 29:1887-1896.
99. 18F]FDG uptake in mouse brain and heart using small animal PET. Nucl. Med. Biol. 2004, 31:251-256.
100. van Kuyck K., Casteels C., Vermaelen P., Bormans G., Nuttin B., Van Laere K. Motor- and food-related metabolic cerebral changes in the activity-based rat model for anorexia nervosa: a voxel-based microPET study. Neuroimage 2007, 35:214-221.
101. Van Laere K.J., Warwick J., Versijpt J., Goethals I., Audenaert K., Van Heerden B., Dierckx R. Analysis of clinical brain SPECT data based on anatomic standardization and reference to normal data: an ROC-based comparison of visual, semiquantitative, and voxel-based methods. J. Nucl. Med. 2002, 43:458-469.
102. Vaupel D.B., Stein E.A., Mukhin A.G. Quantification of alpha4beta2* nicotinic receptors in the rat brain with microPET and 2-[18F]F-A-85380. Neuroimage 2007, 34:1352-1362.
103. Volkow N.D., Gur R.C., Wang G.J., Fowler J.S., Moberg P.J., Ding Y.S., Hitzemann R., Smith G., Logan J. Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. Am. J. Psychiatry 1998, 155:344-349.
104. Volkow N.D., Wang G.J., Maynard L., Jayne M., Fowler J.S., Zhu W., Logan J., Gatley S.J., Ding Y.S., Wong C., Pappas N. Brain dopamine is associated with eating behaviors in humans. Int. J. Eat. Disord. 2003, 33:136-142.
105. Volkow N.D., Wang G.J., Telang F., Fowler J.S., Logan J., Childress A.R., Jayne M., Ma Y., Wong C. Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J. Neurosci. 2006, 26:6583-6588.
106. Wang J.L., Parhi A.K., Oya S., Lieberman B., Kung M.P., Kung H.F. 2-(2'-((Dimethylamino)methyl)-4'-(3-[(18)F]fluoropropoxy)-phenylthio)benze namine for positron emission tomography imaging of serotonin transporters. Nucl. Med. Biol. 2008, 35:447-458.
107. Wang Y., Chan G.L., Holden J.E., Dobko T., Mak E., Schulzer M., Huser J.M., Snow B.J., Ruth T.J., Calne D.B., Stoessl A.J. Age-dependent decline of dopamine D1 receptors in human brain: a PET study. Synapse 1998, 30:56-61.
108. Wise R.A., Spindler J., deWit H., Gerberg G.J. Neuroleptic-induced "anhedonia" in rats: pimozide blocks reward quality of food. Science 1978, 201:262-264.
109. Yang Y.K., Yeh T.L., Chiu N.T., Lee I.H., Chen P.S., Lee L.C., Jeffries K.J. Association between cognitive performance and striatal dopamine binding is higher in timing and motor tasks in patients with schizophrenia. Psychiatry Res. 2004, 131:209-216.
110. Zald D.H., Boileau I., El-Dearedy W., Gunn R., McGlone F., Dichter G.S., Dagher A. Dopamine transmission in the human striatum during monetary reward tasks. J. Neurosci. 2004, 24:4105-4112.
111. 18F-FDG microPET to monitor neural stem cell transplantation in a rat model of traumatic brain injury. Eur. J. Nucl. Med. Mol. Imaging 2008, 35:1699-1708.
112. Zhu A., Wang X., Yu M., Wang J.Q., Brownell A.L. Evaluation of four pyridine analogs to characterize 6-OHDA-induced modulation of mGluR5 function in rat brain using microPET studies. J. Cereb. Blood Flow Metab. 2007, 27:1623-1631.
113. Zimmer L., Mauger G., Le Bars D., Bonmarchand G., Luxen A., Pujol J.F. Effect of endogenous serotonin on the binding of the 5-hT1A PET ligand 18F-MPPF in the rat hippocampus: kinetic beta measurements combined with microdialysis. J. Neurochem. 2002, 80:278-286.